AFAP1 and lung adenocarcinoma: The Kaplan–Meier survival analysis in our study showed no significant effect of AFAP1-AS1 expression on overall survival in lung adenocarcinoma patients, although AFAP1-AS1 expression levels were correlated with tumor progression.